Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Category Archives: Humira

Subscribe to Humira RSS Feed

Humira Recall for Mislabeled Packaging

Posted in Humira

Recently, Abbott Laboratories issued a recall for “four lots of Humira (adalimumab) Pen Psoriasis Starter Package with 4 single use prefilled pens of Humira for subcutaneous use only, 40 mg/0.8mL. The following lots and expiration dates (Exp) are being recalled because the some of the Humira Psoriasis Starter Packages may have been mispackaged with the pens placed… Continue Reading

Humira Use Found to Raise Risk of Infection

Posted in Humira

In 2010, Astrid Wiens et al. published research in Pharmacotherapy demonstrating the danger of Humira®.  Humira® (adalimumab) is a type of TNF inhibitor, a class of chemicals which aim to kill tumor necrosis factor cells in the body.  As TNF cells cause inflammation, the killing of these cells alleviates inflammation in diseases such as rheumatoid arthritis,plaque psoriasis,… Continue Reading